• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

R2 shows lung CAD at ECR

Article

Europe got a look at R2 Technology's lung cancer computer-aided detection March 7 to 11 at the European Congress of Radiology. R2 showcased the CAD software at the Vienna meeting as an integral part of its ImageChecker CT LN-1000 system. A beta unit has

Europe got a look at R2 Technology's lung cancer computer-aided detection March 7 to 11 at the European Congress of Radiology. R2 showcased the CAD software at the Vienna meeting as an integral part of its ImageChecker CT LN-1000 system. A beta unit has been installed at the University of Vienna. Additional installations in Europe will soon follow, according to the company. The ImageChecker CT display workstation offers options that assist review of thoracic CT exams in 2D and 3D formats. These include LungMap for navigation and nodule visualization, as well as automated volume and area measurement tools. To further expand the clinical reach of the product, R2 and Sectra have agreed to integrate the lung analysis software into Sectra's Clinical Solutions Network.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.